Zobrazeno 1 - 10
of 1 462
pro vyhledávání: '"Vijapurkar, U."'
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity, Vol Volume 10, Pp 47-55 (2017)
Michael J Davies,1 Katherine W Merton,1 Ujjwala Vijapurkar,2 Dainius A Balis,2 Mehul Desai2 1Janssen Scientific Affairs, LLC, Titusville, NJ, USA; 2Janssen Research & Development, LLC, Raritan, NJ, USA Objective: Metabolic syndrome refers to a collec
Externí odkaz:
https://doaj.org/article/0fab17479a684dd3b6063eb27630e72e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Khorana AA; Taussig Cancer Institute and Case Comprehensive Cancer Center, and., Barnard J; Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH., Wun T; Division of Hematology and Oncology, University of California Davis School of Medicine, Sacramento, CA; and., Vijapurkar U; Janssen Scientific Affairs, LLC, Titusville, NJ., Damaraju CV; Janssen Scientific Affairs, LLC, Titusville, NJ., Moore KT; Janssen Scientific Affairs, LLC, Titusville, NJ., Wildgoose P; Janssen Scientific Affairs, LLC, Titusville, NJ., McCrae KR; Taussig Cancer Institute and Case Comprehensive Cancer Center, and.
Publikováno v:
Blood advances [Blood Adv] 2022 Feb 22; Vol. 6 (4), pp. 1212-1221.
Autor:
Vadhan-Raj, S., Kuderer, N.M., Wun, T., Patel, J., McCrae, K., Zhou, X., Vijapurkar, U., Damaraju, C.V., Wildgoose, P., Lyman, G.H., Khorana, A.A.
Publikováno v:
In Thrombosis Research April 2021 200 Supplement 1:S12-S12
Publikováno v:
Acta Neurologica Scandinavica; Oct2004, Vol. 110 Issue 4, p221-231, 11p
Autor:
Dika, Živka1,2 (AUTHOR) jelakovicbojan@gmail.com, Živko, Marijana2 (AUTHOR) marina.kljajic7@gmail.com, Kljajić, Marina2 (AUTHOR), Jelaković, Bojan1,2 (AUTHOR)
Publikováno v:
Journal of Clinical Medicine. Oct2024, Vol. 13 Issue 19, p6017. 16p.
Autor:
Popa, Irene Paula1 (AUTHOR) dragomir.serban@umfiasi.ro, Clim, Andreea1 (AUTHOR), Pînzariu, Alin Constantin1 (AUTHOR) alin.pinzariu@umfiasi.ro, Lazăr, Cristina Iuliana1 (AUTHOR), Popa, Ștefan2 (AUTHOR), Tudorancea, Ivona Maria3 (AUTHOR), Moscalu, Mihaela4 (AUTHOR), Șerban, Dragomir N.1 (AUTHOR), Șerban, Ionela Lăcrămioara1 (AUTHOR), Costache-Enache, Irina-Iuliana5,6 (AUTHOR) ii.costache@yahoo.com, Tudorancea, Ionuț1,6 (AUTHOR)
Publikováno v:
Journal of Clinical Medicine. Oct2024, Vol. 13 Issue 19, p5927. 28p.
Autor:
Vadhan-Raj S; The UT MD Anderson Cancer Center, Department of Sarcoma Medical Oncology, Section of Cytokines and Supportive Oncology, Houston, TX, USA., McNamara MG; Department of Medical Oncology, The Christie NHS Foundation Trust & Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom., Venerito M; Klinik für Gastroenterologie, Hepatologie und Infektiologie Universitätsklinikum, Magdeburg, Germany., Riess H; Charité Universitätsmedizin Berlin, Berlin, Germany., O'Reilly EM; Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY, USA., Overman MJ; The UT MD Anderson Cancer Center, Houston, TX, USA., Zhou X; The UT MD Anderson Cancer Center, Department of Sarcoma Medical Oncology, Section of Cytokines and Supportive Oncology, Houston, TX, USA., Vijapurkar U; Janssen Research & Development, LLC, Raritan, NJ, USA., Kaul S; Janssen Scientific Affairs, LLC, Titusville, NJ, USA., Wildgoose P; Janssen Scientific Affairs, LLC, Titusville, NJ, USA., Khorana AA; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA.
Publikováno v:
Cancer medicine [Cancer Med] 2020 Sep; Vol. 9 (17), pp. 6196-6204. Date of Electronic Publication: 2020 Jul 14.
Autor:
Khorana AA; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, Ohio, United States., McNamara MG; Division of Cancer Sciences, Department of Medical Oncology, University of Manchester, The Christie NHS Foundation Trust, Manchester, United Kingdom., Kakkar AK; Thrombosis Research Institute and University College London, London, United Kingdom., Streiff MB; Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States., Riess H; Department of Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany., Vijapurkar U; Clinical Biostatistics, Janssen Research & Development, LLC, Raritan, New Jersey, United States., Kaul S; Medical Affairs Internal Medicine, Janssen Scientific Affairs, LLC, Titusville, New Jersey, United States., Wildgoose P; Medical Affairs Internal Medicine, Janssen Scientific Affairs, LLC, Titusville, New Jersey, United States., Soff GA; Hematology Service, Memorial Sloan Kettering Cancer Center, New York, New York, United States.
Publikováno v:
TH open : companion journal to thrombosis and haemostasis [TH Open] 2020 May 23; Vol. 4 (2), pp. e107-e112. Date of Electronic Publication: 2020 May 23 (Print Publication: 2020).
Autor:
Dorsam, S T, Ferrell, C M, Dorsam, G P, Derynck, M K, Vijapurkar, U, Khodabakhsh, D, Pau, B, Bernstein, H, Haqq, C M, Largman, C, Lawrence, H J
Publikováno v:
Dorsam, S T; Ferrell, C M; Dorsam, G P; Derynck, M K; Vijapurkar, U; Khodabakhsh, D; et al.(2004). The transcriptome of the leukemogenic homeoprotein HOXA9 in human hematopoietic cells. Blood, 103(5), 1676-1684. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/5vc9f28v
Hematopoietic defects in HOXA9(-/-) mice demonstrate a key role for this homeoprotein in blood cell development. Conversely, enforced HOXA9 expression is leukemogenic in mice, and HOXA9 is frequently activated in human acute myeloid leukemia (AML). A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::b7ea5f73f9afd8dd42193f9015892c67
http://www.escholarship.org/uc/item/5vc9f28v
http://www.escholarship.org/uc/item/5vc9f28v
